الصفحة الرئيسية>>Signaling Pathways>> Toxins>> Mycotoxins>>Aflatoxin B2-13C17

Aflatoxin B2-13C17 (Synonyms: AFB2-13C17, Dihydroaflatoxin B1-13C17)

رقم الكتالوجGC46811

An internal standard for the quantification of aflatoxin B2

Products are for research use only. Not for human use. We do not sell to patients.

Aflatoxin B2-13C17 التركيب الكيميائي

Cas No.: 1217470-98-8

الحجم السعر المخزون الكميّة
1.2 ml
1670٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Aflatoxin B2-13C17 (AFB2-13C17) is intended for use as an internal standard for the quantification of AFB2 by GC- or LC-MS. AFB2 is a mycotoxin that has been found in A. terricola.1 It induces hepatic autophagy and apoptosis in broiler chickens when administered at doses of 0.2, 0.4, and 0.8 mg/kg.2 AFB2 (0.5 and 1 mg/animal) also induces parenchymal cell hyperplasia in rats.3

1.Moubasher, A.H., el-Kady, I.A., and Shoriet, A.Toxigenic Aspergilli isolated from different sources in EgyptAnn. Nutr. Aliment.31(4-6)607-615(1977) 2.Chen, B., Li, D., Li, M., et al.Induction of mitochondria-mediated apoptosis and PI3K/Akt/mTOR-mediated autophagy by aflatoxin B2 in hepatocytes of broilersOncotarget7(51)84989-84998(2016) 3.Wogan, G.N., Edwards, G.S., and Newberne, P.M.Structure-activity relationships in toxicity and carcinogenicity of aflatoxins and analogsCancer Res.31(12)1936-1942(1971)

مراجعات

Review for Aflatoxin B2-13C17

Average Rating: 5 ★★★★★ (Based on Reviews and 39 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Aflatoxin B2-13C17

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.